Feature Channels: Biotech

Filters close
Newswise: SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for Treating Patients Who Have Suffered a Heart Attack
Released: 1-Sep-2024 4:05 AM EDT
SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for Treating Patients Who Have Suffered a Heart Attack
Mount Sinai Health System

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.

Newswise: SHRO Scientist Named FDA-AACR Cancer Research Fellow
Released: 30-Aug-2024 4:05 PM EDT
SHRO Scientist Named FDA-AACR Cancer Research Fellow
Sbarro Health Research Organization (SHRO)

Canio Martinelli, M.D., MSc, GYN-OB resident at the University of Messina and visiting Ph.D. student in Translational Molecular Medicine and Surgery at the Sbarro Health Research Organization (SHRO), Temple University, has been honored with the 2024-2025 FDA-AACR Oncology Educational Fellowship.

Newswise: Genomic dark matter solves butterfly evolutionary riddle
Released: 30-Aug-2024 2:05 PM EDT
Genomic dark matter solves butterfly evolutionary riddle
George Washington University

New study reveals how an unexpected genetic mechanism influences the evolution of butterfly wing coloration.

Newswise: Quantitative phase imaging based on holography: trends and new perspectives
Released: 30-Aug-2024 9:05 AM EDT
Quantitative phase imaging based on holography: trends and new perspectives
Chinese Academy of Sciences

In 1948, Dennis Gabor proposed the concept of holography. After 75 years of development, holographic imaging has become a powerful tool for optical wavefront measurement, which has given fresh energy to physics, biology, and materials science. Scientists in China regard the process of holographic recording and reconstruction as a transformation between complex-domain and real-domain, and discuss the mathematics and physical principles of reconstruction. The multidisciplinary nature brings it to label-free biology, wavefront sensing, and semiconductor production.

Released: 30-Aug-2024 8:05 AM EDT
Novel chemical tool aims to streamline drug-making process
Ohio State University

The invention of a tool capable of unlocking previously impossible organic chemical reactions has opened new pathways in the pharmaceutical industry to create effective drugs more quickly.

Newswise: New anti-cancer ‘degrader’ targets protein essential to infant leukemia
Released: 29-Aug-2024 3:05 PM EDT
New anti-cancer ‘degrader’ targets protein essential to infant leukemia
Van Andel Institute

Scientists have developed a potent anti-cancer compound that inhibits cancer cell growth in a tough-to-treat type of infant leukemia.

Newswise: Novel motion simulator reveals key role of airflow in rodent navigation
28-Aug-2024 5:05 AM EDT
Novel motion simulator reveals key role of airflow in rodent navigation
Bar-Ilan University

With the assistance of a novel motion simulator, researchers at Bar-Ilan University in Israel have discovered that rats rely on airflow to navigate their surroundings. When they move, the flow of air relative to their bodies provides crucial information, complementary to their sense of balance, to perceive their own motion in space. This might explain their agility in the dark as they scurry through pipes and tunnels, turn corners, and effortlessly travel from one location to another, all while knowing exactly where they’re headed.

28-Aug-2024 4:05 PM EDT
Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose
Perelman School of Medicine at the University of Pennsylvania

A new tool for monitoring immune health patterns over time reveals how a pair of checkpoint inhibitor therapies works together to recruit new cancer-fighting T cells with every infusion.

Released: 29-Aug-2024 8:05 AM EDT
A bacterial defense with potential application in genome editing
Ohio State University

Scientists who have described in a new study the step-by-step details of a bacterial defense strategy see the mechanism as a promising platform for development of a new genome-editing method.

   
Released: 29-Aug-2024 6:05 AM EDT
EVOQ Therapeutics Secures $2 Million in Funding for Advanced Autoimmune NanoDisc Therapies
EVOQ Therapeutics, Inc.

EVOQ Therapeutics, Inc. (EVOQ) a biopharmaceutical company dedicated to the treatment of autoimmune diseases, announced today the receipt of a $2 million grant from the National Institutes of Health (NIH) to advance novel therapies for autoimmune diseases.

Newswise: Researchers Use a New Two-Dimensional Analysis to Build a Map of Gene Expression in Plant-Fungi Interactions
Released: 28-Aug-2024 2:05 PM EDT
Researchers Use a New Two-Dimensional Analysis to Build a Map of Gene Expression in Plant-Fungi Interactions
Department of Energy, Office of Science

Researchers studied gene expression in plant/mycorrhizae symbioses by analyzing the roots of a model plant colonized by fungi and using a combination of techniques to measure gene activity in individual cells and visualize gene expression within two-dimensional sections of roots.

Released: 28-Aug-2024 12:05 PM EDT
Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed as New Director of the Institute for Genome Sciences at the University of Maryland School of Medicine
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Elana J. Fertig, PhD, FAIMBE, as the new Director of the School’s Institute for Genome Sciences (IGS).

Newswise: Fighting fungal foes: walnut's genetic armor against anthracnose revealed
Released: 28-Aug-2024 11:05 AM EDT
Fighting fungal foes: walnut's genetic armor against anthracnose revealed
Chinese Academy of Sciences

A pivotal study has pinpointed a gene module crucial for enhancing walnut trees' resistance to anthracnose, a widespread fungal disease threatening the walnut industry.

Newswise: CFA4163la.jpg
Released: 28-Aug-2024 10:05 AM EDT
Swifter simulations for modern science. All of it
Sandia National Laboratories

In a machine learning paper recently published in the journal npj Computational Materials, a team of researchers from Sandia National Laboratories and Brown University have introduced a universal way to accelerate virtually any kind of simulation.

Newswise: Chloroplast manipulation: a new strategy in pathogen warfare uncovered
Released: 28-Aug-2024 10:05 AM EDT
Chloroplast manipulation: a new strategy in pathogen warfare uncovered
Chinese Academy of Sciences

A cutting-edge study has unveiled the sophisticated methods pathogens use to weaken plant defenses. It shows how a pathogen's effector protein targets the chloroplast protein StFC-II, increasing its levels in chloroplasts and reducing the plant's ability to generate reactive oxygen species (ROS). This manipulation significantly compromises the plant's immune response, offering new insights into potential strategies for enhancing plant resistance to infections.

Newswise: What Is Gene Therapy?
Released: 28-Aug-2024 6:05 AM EDT
What Is Gene Therapy?
Children's Hospital Los Angeles

Every cell in your body holds a unique genetic code within your DNA, inherited from your parents. The segments of your DNA called genes determine nearly all your body’s characteristics and functions.

Newswise: Illinois researchers develop near-infrared spectroscopy models to analyze corn kernels, biomass
Released: 27-Aug-2024 3:05 PM EDT
Illinois researchers develop near-infrared spectroscopy models to analyze corn kernels, biomass
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

In the agricultural and food industry, determining the chemical composition of raw materials is important for production efficiency, application, and price. Traditional laboratory testing is time-consuming, complicated, and expensive. New research from the University of Illinois Urbana-Champaign demonstrates that near-infrared (NIR) spectroscopy and machine learning can provide quick, accurate, and cost-effective product analysis.

Newswise: UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy
Released: 27-Aug-2024 12:00 PM EDT
UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy
University of California, Los Angeles (UCLA), Health Sciences

UCLA has received a $120 million commitment from Dr. Gary Michelson and his wife, Alya, to kick-start the California Institute for Immunology and Immunotherapy, an innovative public-private partnership aimed at spurring breakthrough discoveries that prevent and cure diseases and catalyze economic growth and innovation in Los Angeles.

   
Newswise: 1920_nirdesh-gupta-cedars-sinai.jpg?10000
Released: 27-Aug-2024 11:05 AM EDT
Cedars-Sinai Intellectual Property Company Names New Managing Partner
Cedars-Sinai

Nirdesh K. Gupta, PhD, has been named the new managing partner of the Cedars-Sinai Intellectual Property Company (CSIP Co.). The new role recognizes Gupta’s expanded scope of management responsibilities over Cedars-Sinai’s technology transfer, venture building, investments and other intellectual property-related initiatives at CSIP Co.



close
2.47793